SASKIA CHASKELSON: Open Payments
NPI 1417578873 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 20 payments from 12 companies in 2025. Trend: 2023 $149 · 2024 $168 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $68 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $55 |
| Evofem Biosciences, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $48 |
| Dexcom, Inc. | 2 | $47 |
| PFIZER INC. | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MYFEMBREE, Phexxi, Veozah, Dexcom G6 Transmitter, ABRYSVO, ZURZUVAE, Wegovy, SLYND.
Industry payments across MO — which companies pay providers there.
